Figure 3From: Pathologic response with neoadjuvant chemotherapy and stereotactic body radiotherapy for borderline resectable and locally-advanced pancreatic cancerKaplan-Meier curves for progression-free survival (Panel A) and overall survival (Panel B). The median progression free survival was 27.4 months. The median overall survival is 47.2 months. Overall survival is 92%, 64% and 51% at 1-, 2- and 3-years respectively.Back to article page